In pancreatic beta cells, mitochondrial bioenergetics control glucose-stimulated insulin secretion (GSIS). Mitochondrial dynamics are generally associated with quality control, maintaining the functionality of bioenergetics. By acute pharmacological inhibition of mitochondrial fission protein Drp1, we here demonstrate that mitochondrial fission is necessary for GSIS in mouse and human islets. We confirm that genetic silencing of Drp1 increases mitochondrial proton leak in MIN6 cells. However, our comprehensive analysis of pancreatic islet bioenergetics reveals that Drp1 does not control insulin secretion via its effect on proton leak but instead via modulation of glucose-fuelled respiration. Notably, pyruvate fully rescues the impaired insulin secretion of fission-deficient beta cells, demonstrating that defective mitochondrial dynamics solely impact substrate supply upstream of oxidative phosphorylation. The present findings provide novel insights in how mitochondrial dysfunction may cause pancreatic beta cell failure. In addition, the results will stimulate new thinking in the intersecting fields of mitochondrial dynamics and bioenergetics, as treatment of defective dynamics in mitochondrial diseases appears to be possible by improving metabolism upstream of mitochondria.
Abstract
In pancreatic beta cells, mitochondrial bioenergetics control glucose-stimulated insulin secretion (GSIS). Mitochondrial dynamics are generally associated with quality control, maintaining the functionality of bioenergetics. By acute pharmacological inhibition of mitochondrial fission protein Drp1, we here demonstrate that mitochondrial fission is necessary for GSIS in mouse and human islets. We confirm that genetic silencing of Drp1 increases mitochondrial proton leak in MIN6 cells. However, our comprehensive analysis of pancreatic islet bioenergetics reveals that Drp1 does not control insulin secretion via its effect on proton leak but instead via modulation of glucose-fuelled respiration. Notably, pyruvate fully rescues the impaired insulin secretion of fission-deficient beta cells, demonstrating that defective mitochondrial dynamics solely impact substrate supply upstream of oxidative phosphorylation. The present findings provide novel insights in how mitochondrial dysfunction may cause pancreatic beta cell failure. In addition, the results will stimulate new thinking in the intersecting fields of mitochondrial dynamics and bioenergetics, as treatment of defective dynamics in mitochondrial diseases appears to be possible by improving metabolism upstream of mitochondria.
The development of type-2 diabetes mellitus is associated with mitochondrial dysfunction in pancreatic beta-(β)-cells. β-cells have developed highly coordinated mechanisms that link glucose sensing with metabolic signaling cascades that direct the secretion of sufficient insulin to maintain glucose homeostasis [1] . The mechanism underlying glucose-stimulated insulin secretion (GSIS) from β-cells involves glucose uptake by specific glucose transporters followed by glucose catabolism through glycolysis yielding pyruvate, which in turn is further catabolized via the tricarboxylic (TCA) cycle. Both glycolysis and TCA-cycle turnover generate reducing power that is used by the mitochondrial respiratory chain to produce ATP through oxidative phosphorylation. The resultant increase in the cytosolic ATP/ADP ratio closes ATP-sensitive K + (K ATP ) channels, thus depolarizing the plasma membrane. Depolarization triggers opening of voltage-gated Ca 2+ channels, and the influx of Ca 2+ ions consequently leads to exocytosis of insulin-containing granules from β-cells [2] . This sequence of events illustrates that β-cell mitochondria exert strong control over GSIS [3] as mitochondrial energy-transducing processes dictate how fast and efficiently glucose is converted to ATP. Mitochondrial dysfunction impairs glucose-insulin secretion coupling and ultimately promotes β-cell apoptosis and death, one of the key features of type-2 diabetes (T2D) [4] .
Mitochondria are dynamic organelles that are constantly remodeled through the opposing action of fission and fusion proteins [5] . Until recently, the influence of mitochondrial dynamics over energy transduction has been under-appreciated. The continuous changes in mitochondrial morphology are controlled by a group of evolutionarily highly-conserved large GTPases of the dynamin superfamily [5] .
Mitochondrial fusion is regulated by mitofusins 1 and 2 (Mfn1/2) and optic-atrophy 1 (Opa1), whereas mitochondrial fission is regulated by dynamin-related protein 1 (Drp1) and fission protein 1 (Fis1) [6] . Increasing evidence suggests that a subtle balance between mitochondrial fission and fusion events is crucial for achieving the mitochondrial morphology required for a particular (energetic) function [7] [8] [9] .
Deficiencies in the proteins regulating mitochondrial dynamics have been associated with several human diseases including dominant Optic Atrophy for Opa1, CharcotMarie-Tooth disease type 2A for Mfn2, and developmental defects for Drp1 [10] [11] [12] .
Indeed, there is evidence that the pancreatic islets of diabetic patients exhibit swollen and enlarged mitochondria, implying disturbed mitochondrial morphology under diabetic conditions [13] .
The GTPase gene Drp1 is considered pivotal for regulating mitochondrial fission [14] . In response to metabolic demand, Drp1 translocates from the cytoplasm to the mitochondrial surface where it forms a complex with Fis1. Oligomerization of Drp1 provides the mechanical force required to constrict the mitochondrial membranes and thereby facilitate fission [15] . Recent studies suggest that Drp1 recruitment involves post-translational modifications including sumoylation, Snitrosylation, ubiquitination, and phosphorylation [16, 17] . Interestingly, Drp1 activation under glucolipotoxic conditions in pancreatic β-cells leads to abnormalities in mitochondrial structure and function, followed by activation of pro-apoptotic signaling cascades [18] [19] [20] [21] . It has recently been reported that manipulation of mitochondrial morphology by overexpressing dominant-negative Drp1 (DN-Drp1) with erased GTPase activity decreases GSIS in INS-1E insulinoma cells, and this was attributed to increased mitochondrial proton leak [22] . Collectively, these findings emphasize the important role of mitochondrial dynamics in pancreatic β-cell biology, although exact mechanisms have yet to be established firmly.
In the present study, we used genetic and pharmacological inactivation of 
Research Design and Methods
Human and mouse islets -Human islets were provided through the JDRF award 31- [24] . In short, "basal respiration" represents mitochondrial respiration rates at 2 mM glucose, and "ATP linked respiration" represents the respiration rates prior to injection of oligomycin minus oligomycin-insensitive rates. Oligomycininsensitive rates are labeled "proton leak respiration". The coupling efficiency represents the fraction of respiration used to drive ATP synthesis for each run, calculated as CE = 1-(proton leak/respiration prior to oligomycin-injection).
Islet bioenergetics -Batches of equal numbers of islets were plated into XF24-well islet culture plates and washed twice with bicarbonate-free KRH buffer supplemented with 2 mM glucose. The islets were starved in the same buffer with and without 100 µM mdivi-1 for 1 h at 37 0 C in a non-CO 2 incubator. The plate was then placed into the machine (controlled at 37°C) for a 10-min calibration followed by four measurement cycles to record basal cellular respiration. Islets were then treated sequentially with glucose (16.5 mM), oligomycin (10 µg/ml), and a mixture of rotenone/antimycin A (R/A; both 2 µM Statistical analysis -Data were collected from several independent experiments and results are expressed as means ± SEM. Unpaired 2-tailed student t-tests were used to compare two variables, and one-way ANOVA (with Bonferroni posthoc analysis) was used for multiple comparisons using Graph-Pad prism version 6.0. Statistically significant differences were considered at p<0.05 (*), p<0.01 (**) and p<0.001 (***).
Results

Drp1 knockdown changes mitochondrial morphology and decreases GSIS
MIN6 cells targeted with specific shRNA express ~50% less Drp1 mRNA (Fig. 1a) and 80% less protein (Fig. 1b) than non-targeted control cells. Drp1 knockdown (KD) did not affect Mfn1 or Opa1 mRNA levels but caused an increase in Mfn2 mRNA, consistent with the concept that mitochondrial elongation is supported (Fig. 1c) .
Moreover, fluorescent visualization of the mitochondrial network revealed elongated mitochondria in Drp1 KD cells; i.e., it demonstrated the expected morphological changes (Fig. 1d, e) . Western analysis of representative subunits from all respiratory complexes (gene names are found in Fig. 1f ) confirms that Drp1 KD does not affect the composition of the mitochondrial electron-transfer chain (Fig. 1f) . Equally, Drp1
KD leaves the insulin content of MIN6 cells unaffected (Fig. 1g) , although it lowered Ins2 (not Ins1) mRNA (Fig. 1h ).
Basal insulin release at 2 mM glucose was not affected by Drp1 KD, but insulin secretion at 16.5 mM glucose was significantly decreased (Fig. 2a) , strongly implicating mitochondrial dynamics in the control of nutrient-secretion coupling in pancreatic β-cells. Drp1 KD did not affect insulin secretion mechanisms downstream of mitochondria, as neither KCl-nor glyburide-provoked insulin release was changed (Fig. 2a) . In the presence of low glucose levels (2 mM), potassium served to depolarize the plasma membrane while glyburide, a sulfonylurea, specifically closes ATP-dependent potassium channels. These findings strongly suggest that Drp1 KD decreases GSIS through deleterious effects on glucose catabolism.
Drp1 knockdown lowers coupling efficiency of oxidative phosphorylation
Real-time oxidative breakdown of glucose can be followed readily in intact cells by measuring mitochondrial oxygen uptake utilizing Seahorse technology [25] . Using this plate-based respirometry platform, we measured basal respiratory activity of KD and control cells (Fig. 2c) , although glucose-stimulated respiration tended to be lower in Drp1 KD cells (Fig. 2c) . Interestingly, Drp1 depletion from MIN6 cells lowered mitochondrial respiration that is used to make ATP at high glucose ( Fig. 2d) , a statistically significant effect reflected by decreased coupling efficiency of glucosestimulated oxidative phosphorylation (Fig. 2e ). This relatively low coupling efficiency also reflects an increase in mitochondrial proton leak that is provoked by Drp1 KD at high glucose (Fig. 2f) . Note that the concomitant changes in oxygen consumption linked to proton leak (increase) and ATP synthesis (decrease) neutralize each other, such that overall glucose-stimulated respiration does not differ significantly between Drp1 KD and control cells ( We preincubated MIN6 cells with 25 or 50 µM mdivi-1 at basal and stimulatory glucose levels and found that mdivi-1 has no effect on insulin content (Fig. 3a) or basal insulin release (Fig. 3b) . GSIS, however, is dose-dependently lowered by mdivi-1, reaching statistical significance at 50 µM (Fig. 3b ). These mdivi-1 effects echo those observed after Drp1 KD (Fig. 2a) . Equally, mdivi-1 fully mimicked the bioenergetic effects of Drp1 KD: basal and glucose-stimulated respiration was unaffected by 50µM mdivi-1 ( Fig. 3c ), while mitochondrial proton leak was increased ( Fig. 3d ) and respiration used to make ATP was decreased (Fig. 3e) . Consequently, mdivi-1 blunts the coupling efficiency of glucose-stimulated oxidative phosphorylation ( Fig. 3f ). Increasing the mdivi-1 dose to 100 µM had no further impact on the bioenergetics of the MIN6 cells, suggesting that 50 µM represents the fully inhibitory dose (suppl. Fig. 2 ). To investigate the translational potential of fission-dependent GSIS, we incubated human pancreatic islets with mdivi-1 and, consistent with the cellular data, observed no effect on insulin content or basal insulin release but saw a significant decrease of GSIS (Fig. 4a, b, c) . These results collectively demonstrate that inhibition of Drp1-mediated mitochondrial fission by mdivi-1 controls GSIS in both human pancreatic islets and cultured β-cells.
Mdivi-1 decreases GSIS in pancreatic islets by decreasing oxidative capacity
To explore the physiological and pathological relevance of Drp1, we studied the effect of mdivi-1 treatment on islets isolated from mice. Consistent with human islet and MIN6 cell data, mdivi-1 did not alter insulin content but attenuated GSIS (Fig.   4d , e, f). Representative real-time respiratory measurements under control conditions in islet-capture plates are depicted in Fig. 4g (see Research Design and Methods).
Mdivi-1 did not affect basal islet respiration at the low glucose concentration but significantly lowered glucose-stimulated respiration at the higher concentration ( (Fig. 4j) , which is why its inhibitory effect on ATP-synthesis-coupled respiration is apparent from the overall glucose-stimulated oxygen consumption in islets (Fig. 4h ). Consequent to its lowering effect on glucose oxidation linked to ATP synthesis, mdivi-1 significantly decreased the coupling efficiency of mouse islets (Fig. 4k) . Collectively, these data demonstrate that Drp1 controls islet GSIS by regulating glucose oxidation, and not proton leak.
Pyruvate rescues impaired function of Drp1-deficient cells and islets
We hypothesized that the impaired glucose oxidation is likely secondary to reduced mitochondrial substrate supply, and we assessed this by directly providing pyruvate to mitochondria. We observed that the impaired GSIS of Drp1-depleted MIN6 cells could be entirely rescued by supplying the cells with exogenous pyruvate (Fig. 5a, b ).
This observation suggests that pyruvate either circumvents defects in glucose-fuelled ATP production or else triggers insulin secretion downstream of mitochondria.
Pyruvate augments glucose-stimulated oxygen uptake in MIN6 cells irrespective of the presence of Drp1 (Fig. 5c ). The stimulatory effect of pyruvate on glucose oxidation was mirrored by a (not statistically significant) boost of GSIS in control and Drp1-depleted cells (Fig. 5a ). Pyruvate stimulation restores ATP-synthesis-linked respiration in Drp1-deficient cells to the level seen in control cells incubated at high glucose (Fig. 5d) . The restorative effect of pyruvate is not evident from coupling efficiency (Fig. 5e ), which remained low after pyruvate supplementation because of the persistently high mitochondrial proton leak exhibited by Drp1 KD cells (Fig. 5f ).
Pyruvate thus rescues GSIS despite relatively high proton leak activity, demonstrating
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that GSIS impairment in Drp1-deficient cells is predominantly caused by decreased ATP synthesis ability. This conclusion is supported by the increased ATP content in pyruvate-treated cells (Fig. 5g, h ). The restored ATP levels suggest that glucosefueled oxidative phosphorylation in Drp1-deficient MIN6 cells is limited upstream of pyruvate; i.e., at the level of glycolysis. Glucose transporter gene expression and glucose uptake are not negatively affected in Drp1 KD cells (Fig. 5i, j) and positive trends are rather suggesting deficiencies downstream of glucose transport.
Interestingly, the use of glucokinase activator GKA50 improved glucose oxidation in Drp1 KD cells and rescued GSIS (Fig. 5k, l ).
It is difficult to gauge the translational potential of this pyruvate effect as native β-cells lack the monocarboxylate carrier protein that allows insulinoma cells to take up pyruvate [1] . Therefore, we tested the effect of pyruvate supplementation on mouse pancreatic islets treated with mdivi-1. GSIS deficiency was not rescued by sodium pyruvate in mouse pancreatic islets (Fig. 6a, b) , thus excluding the possibility that pyruvate acts as an extracellular secretagogue that enhances secretory mechanisms downstream of mitochondria. However, GSIS impairment was entirely overcome by the membrane-permeant methyl pyruvate (Fig. 6a, b) . Indeed, methyl pyruvate is also able to provoke insulin secretion in Drp1-inhibited mouse islets in the absence of glucose. One-hour incubation with methyl-pyruvate fully rescued the Drp1-dependent deficiency of triggered insulin secretion in the presence and absence of 16.5 mM glucose (Fig. 6a) . The respective respiration measurements indicate that methylpyruvate acts as a mitochondrial substrate by increasing mitochondrial respiration (Fig. 6c) . Despite some increase in proton leak respiration when glucose and methylpyruvate are combined (Fig. 6d) , methyl pyruvate treatment overcomes Drp1-dependent differences in ATP-synthesis-linked respiration (Fig. 6e) . Moreover, the mdivi-1-invoked difference in coupling efficiency is ameliorated by methyl pyruvate treatment (Fig. 6f) . These findings suggest a model (Fig. 6g) that predicts that direct substrate delivery to mitochondria may be pursued as a potential route for drug intervention to rescue fission-impaired GSIS.
Discussion
The present findings provide important insight into the mechanism by which the mitochondrial fission protein Drp1 controls pancreatic insulin secretion. Specifically, the data demonstrate that Drp1-mediated mitochondrial fragmentation ensures that mitochondria are supplied with sufficient reducing power during GSIS. We Although the rescue by pyruvate argues against a role for the mitochondrial pyruvate carrier (MPC) during limited substrate supply in Drp1-deficient systems, restricted pyruvate transport can also not be formally excluded at this stage.
Our experiments highlight how modern technologies for measuring cellular and islet bioenergetics (such as real-time multi-well-plate-based respirometry) improve our understanding of insulin secretion by pancreatic β-cells. Nutrientsecretion coupling depends to a large degree on the link between glucose catabolism and ATP-triggered signaling events that lead to the exocytosis of insulin-containing granules. The strength of nutrient-secretion coupling is largely determined by the extent to which energy liberated during glucose combustion is used to make ATP, and by how much of it is wasted via mitochondrial proton leak. Coupling efficiency of oxidative phosphorylation is an often underestimated bioenergetic parameter that is highly critical for β-cell biology as it quantifies the proportion of glucose-fueled respiration that is coupled to ATP synthesis. As coupling efficiency is an internally normalized parameter, it benefits from a comparably high signal-to-noise ratio that renders it exquisitely sensitive to any perturbation in proton leak, mitochondrial ATP synthesis and/or cellular substrate oxidation [31] . Indeed, changes in coupling efficiency following Drp1 silencing underpin our discovery that glycolytic substrate delivery to mitochondria is the single parameter that controls insulin secretion, while direct effects on energy transduction (proton leak) play a minor role. 
Supplementary experimental procedures a. Human and mouse islet culture conditions
Human islets -Prior to experimentation, human islets (from three different donors) were cultured 
15
Mean mitochondrial length with 10% human serum, 100 units/ml penicillin, 100 µg/ml streptomycin and 2 mM glutamine (Life technologies) at 37°C and 5% CO 2 . 
d. Glucose uptake assay
MIN6 cells were seeded and preincubated, using the same procedure as those employed for determination of insulin secretion. Cells were then incubated with 10 mM glucose and 5 mM 2-deoxyglucose (2-DG) for 2 h. Later, the medium was removed and cells were washed. 2-DG was determined using the calorimetric Glucose Uptake assay kit (Abcam) according to the manufacturer's protocol. Results were corrected for DNA content.
e. Western blot analysis and RNA isolation and RT-PCR
Western blot analysis -Cells were rinsed with ice-cold Dulbecco's PBS and incubated with RIPA lysis buffer containing a cocktail of protease and phosphatase inhibitors. After sonication for 10 sec, cell lysates were centrifuged at 12000 g for 10 min. The protein concentration was determined using a BCA protein assay kit (Thermo scientific) according to the manufacturer's protocol. Protein lysates were prepared in Nu-PAGE LDS sample buffer (Novex). Equal amounts of total cell protein were separated by 10% or 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto nitrocellulose membrane (Bio-Rad). The membranes were blocked for 1 h in TBS-T containing 5% (w/v) BSA at room temperature and then probed overnight at 4 0 C with appropriate primary antibodies: anti-Drp1
(BD Bioscience), anti-alpha tubulin (Santa Cruz biotechnology) and anti-actin (Cell signaling).
After three washes with TBS-T, membranes were incubated with respective horse peroxidaseconjugated secondary antibodies (Santa Cruz biotechnology) for 1 h in TBS-T containing 5%
(w/v) BSA at room temperature. After three washes with TBS-T, the membranes were detected using a chemiluminescence detection system (LI-COR Biosciences). Quantification of band density was performed by densitometric analysis and normalized against alpha tubulin and actin values.
RNA isolation and RT-PCR -At the end of experiment, cells were rinsed with ice-cold Dulbecco's PBS and total RNA was extracted using an RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions. RNA concentration and purity were determined using a Nano drop spectrophotometer (Thermo scientific). cDNA was synthesized from 1 µg of total RNA using a QuantiTect Reverse Transcription Kit (Qiagen) according to the manufacturer's instructions. cDNA was then subjected to real time-PCR using SYBR Green premix (Applied Biosystem). HPRT was used as an internal control. Primers used for real time PCR are listed in Table 1 .
